Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone
Launched by UNIVERSITY OF NEBRASKA · Dec 21, 2007
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this study is to determine if a combination of methotrexate and minocycline works better than methotrexate alone in early Rheumatoid Arthritis (RA). Specific aims of this study are:
A. To demonstrate that the combination of minocycline and methotrexate is well tolerated when used in the first year of RA.
B. To compare the efficacy of the combination of minocycline and methotrexate with methotrexate and placebo therapy in early sero-positive RA patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age over or equal to 19 years old and less than or equal to 75 years old
- • Diagnosis of RA as determined by fulfilling 4 of 7 ACR criteria
- • Positive rheumatoid factor
- • Duration of disease: greater than six weeks and less than one year
- Exclusion Criteria:
- • Allergy to tetracycline or methotrexate
- • Previous DMARD treatment
- • Doses of oral steroids greater than 7.5 mg/day
- • Intra-articular injections within the last four weeks
- • Significant liver or renal disease or active peptic ulcer disease
- • Patients who are not willing to abstain from alcohol consumption
- • Women of childbearing potential who are not practicing a successful method of contraception
About University Of Nebraska
The University of Nebraska is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong commitment to improving patient outcomes and fostering scientific discovery, the university collaborates with various healthcare professionals and researchers to conduct rigorous clinical studies across diverse medical fields. The institution prioritizes ethical standards and patient safety while striving to translate research findings into practical solutions that enhance medical practices and contribute to the overall well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Omaha, Nebraska, United States
Patients applied
Trial Officials
James R O'Dell, MD
Principal Investigator
University of Nebraska
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials